Involvement of outer membrane proteins and peroxide-sensor genes in Burkholderia cepacia resistance to isothiazolone

World Journal of Microbiology and Biotechnology

Volumn 30, Issue 4, 2014, Pages 1251-1260

  Zhou, Gang ^a   Shi, Qing shan ^a   Ouyang, You sheng ^a   Chen, Yi ben ^a  

^a GUANGDONG INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Biocide resistance properties; Burkholderia cepacia; Kathon preservative; Outer membrane proteins; Peroxide sensor genes

Indexed keywords

BIOCIDE RESISTANCE; BURKHOLDERIA CEPACIA; INDUSTRIAL CONTAMINATION; KATHON PRESERVATIVE; OUTER MEMBRANE PROTEIN; RESISTANCE PROPERTIES; SUPER OXIDE DISMUTASE; TRANSCRIPTIONAL ACTIVATORS;

BIOCIDES; BIOLOGICAL MEMBRANES; GENES; OXIDATION; OXYGEN; PEROXIDES; SODIUM DODECYL SULFATE;

SENSORS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA;

ANTIINFECTIVE AGENT; ENZYME; KATHON 886; OUTER MEMBRANE PROTEIN; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR;

ANTIBIOTIC RESISTANCE; BURKHOLDERIA CEPACIA; DRUG EFFECTS; METABOLISM;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BURKHOLDERIA CEPACIA; DRUG RESISTANCE, BACTERIAL; ENZYMES; THIAZOLES; TRANSCRIPTION FACTORS;

EID: 84900575458     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-013-1538-3     Document Type: Article

References (42)

1. Adibpour N, Khalaj A, Rezaee S, Daneshtalab M (2007) In vitro antifungal activity of 2-(4-substituted phenyl)-3(2H)-isothiazolones. Folia Microbiol 52: 573-576.
2. Adibpour N, Khalaj A, Rajabalian S (2010) Synthesis and antibacterial activity of isothiazolyl oxazolidinones and analogous 3(2H)-isothiazolones. Eur J Med Chem 45: 19-24.
3. Bogman K, Erne-Brand F, Alsenz J, Drewe J (2003) The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J Pharm Sci 92: 1250-1261.
4. Brözel VS, Cloete TE (1994) Resistance of Pseudomonas aeruginosa to isothiazolone. J Appl Bacteriol 76: 576-582.
5. Chapman JS, Diehl MA (1995) Methylchloroisothiazolone-induced growth inhibition and lethality in Escherichia coli. J Appl Microbiol 78: 134-141.
6. Chapman JS, Diehl MA, Fearnside KB (1998) Preservative tolerance and resistance. Int J Cosmet Sci 20: 31-39.
7. Cheng JJ, Thanassi JA, Thoma CL, Bradbury BJ, Deshpande M, Pucci MJ (2007) Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus. Antimicrob Agents Chemother 51: 2445-2453.
8. Cloete TE (2003) Resistance mechanisms of bacteria to antimicrobial compounds. Int Biodeterior Biodegradation 51: 277-282.
9. Collier PJ, Austin P, Gilbert P (1990a) Uptake and distribution of some isothiazolone biocides into Escherichia coli ATCC 8739 and Schizosaccharomyces pombe NCYC 1354. Int J Pharm 66: 201-206.
10. Collier PJ, Ramsey AJ, Austin P, Gilbert P (1990b) Growth inhibitory and biocidal activity of some isothiazolone biocides. J Appl Microbiol 69: 569-577.
11. Collier PJ, Austin P, Gilbert P (1991) Isothiazolone biocides: enzyme-inhibiting pro-drugs. Int J Pharm 74: 195-201.
12. El Abdellaoui H, Varaprasad CVNS, Barawkar D, Chakravarty S, Maderna A, Tam R, Chen HM, Allan M, Wu JZ, Appleby T, Yan SQ, Zhang WJ, Lang S, Yao NH, Hamatake R, Hong Z (2006) Identification of isothiazole-4-carboxamidines derivatives as a novel class of allosteric MEK1 inhibitors. Bioorg Med Chem Lett 16: 5561-5566.
13. Ettorre A, Andreassi M, Anselmi C, Neri P, Andreassi L, Di Stefano A (2003) Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes. J Invest Dermatol 121: 328-336.
14. Furdas SD, Shekfeh S, Bissinger EM, Wagner JM, Schlimme S, Valkov V, Hendzel M, Jung M, Sippl W (2011) Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors. Bioorgan Med Chem 19: 3678-3689.
15. Gedi V, Moon JY, Lim WM, Lee MY, Lee SC, Koo BS, Govindwar S, Yoon MY (2011) Identification and characterization of inhibitors of Haemophilus influenzae acetohydroxyacid synthase. Enzyme Microb Technol 49: 1-5.
16. 2 and gamma radiation. J Bacteriol 168: 1026-1029.
17. Howard-Flanders P, Theriot L (1966) Mutants of Escherichia coli K-12 defective in DNA repair and in genetic recombination. Genetics 53: 1137-1150.
18. Jimenez L, Smalls S (2000) Molecular detection of Burkholderia cepacia in toiletry, cosmetic, and pharmaceutical raw materials and finished products. J AOAC Int 83: 963-966.
19. Khalaj A, Adibpour N, Shahverdi AR, Daneshtalab M (2004) Synthesis and antibacterial activity of 2-(4-substituted phenyl)-3(2H)-isothiazolones. Eur J Med Chem 39: 699-705.
20. King A, Lodola A, Carmi C, Fu J, Mor M, Piomelli D (2009) A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. Brit J Pharmacol 157: 974-983.
21. Kiselyov AS, Semenova M, Semenov VV (2009) 3, 4-Disubstituted isothiazoles: novel potent inhibitors of VEGF receptors 1 and 2. Bioorg Med Chem Lett 19: 1195-1198.
22. Leive L (1968) Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. J Biol Chem 243: 2373-2380.
23. Lewin C, Doherty C, Govan J (1993) In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother 37: 123-125.
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 25: 402-408.
25. Palleroni NJ (2005) Genus I. Burkholderia. In: Garrity GM (ed) Bergey's manual of systematic bacteriology, 2nd edn. Volume 2: The Proteobacteria, Part C: The Alpha-, Beta-, Delta-, and Epsilonproteobacteria. Springer, New York, pp 575-600.
26. Pedras MS, Suchy M (2006) Design, synthesis, and antifungal activity of inhibitors of brassilexin detoxification in the plant pathogenic fungus Leptosphaeria maculans. Bioorg Med Chem 14: 714-723.
27. Pucci MJ, Cheng JJ, Podos SD, Thoma CL, Thanassi JA, Buechter DD, Mushtaq G, Vigliotti GA, Bradbury BJ, Deshpande M (2007) In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. Antimicrob Agents Chemother 51: 1259-1267.
28. Pucci MJ, Podos SD, Thanassi JA, Leggio MJ, Bradbury BJ, Deshpande M (2011) In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens. Antimicrob Agents Chemother 55: 2860-2871.
29. Reddy BM, Tanneeru K, Meetei PA, Guruprasad L (2011) 3D-QSAR and molecular docking studies on substituted isothiazole analogs as inhibitors against MEK-1 kinase. Chem Biol Drug Des 79: 84-91.
30. Rushton L, Sass A, Baldwin A, Dowson CG, Donoghue D, Mahenthiralingam E (2013) Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria. Antimicrob Agents Chemother 57: 2972-2980.
31. Sharmeen L, McQuade T, Heldsinger A, Gogliotti R, Domagala J, Gracheck S (2001) Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374. Antiviral Res 49: 101-114.
32. Speksnijder P, van Ravestijn J, de Voogt P (2010) Trace analysis of isothiazolinones in water samples by large-volume direct injection liquid chromatography tandem mass spectrometry. J Chromatogr A 1217: 5184-5189.
33. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4. 0. Mol Biol Evol 24: 1596-1599.
34. Tang QY, Feng MG (2007) DPS data processing system: experimental design, statistical analysis and data mining. Science Press, Beijing.
35. Tattawasart U, Maillard JY, Furr JR, Russell AD (2000) Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine diacetate and cetylpyridinium chloride. Int J Antimicrob Agents 16: 233-238.
36. Vermis K, Vandamme P, Nelis HJ (2003) Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. J Appl Microbiol 95: 1191-1199.
37. Vicentini CB, Romagnoli C, Manfredini S, Rossi D, Mares D (2011) Pyrazolo [3, 4-c]isothiazole and isothiazolo [4, 3-d]isoxazole derivatives as antifungal agents. Pharm Biol 49: 545-552.
38. Williams TM (2007) The mechanism of action of isothiazolone biocide. Power Plant Chem 9: 14-22.
39. Winder CL, Al-Adham IS, Abdel Malek SM, Buultjens TE, Horrocks AJ, Collier PJ (2000) Outer membrane protein shifts in biocide-resistant Pseudomonas aeruginosa PAO1. J Appl Microbiol 89: 289-295.
40. Woodcock D, Linsenmeyer M, Chojnowski G, Kriegler A, Nink V, Webster L, Sawyer W (1992) Reversal of multidrug resistance by surfactants. Br J Cancer 66: 62.
41. Xu FL, Lin Q, Hou BR (2009) Synthesis and bioactivity of novel benzisothiazolone derivatives as potential microbiocides. J Heterocycl Chem 46: 320-323.
42. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, Ezaki T, Arakawa M (1992) Proposal of Burkholderia gen. nov; and transfer of seven species of the Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 36: 1251-1275.